Implementation of the FENIX assay to assess the anti-ferroptotic properties of test compounds
Methods in Cell Biology · 2026 · 63-83
DOI: 10.1016/bs.mcb.2026.01.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Cell Biology, 2026. Verfasst von Juliana A Hüther und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany. Hauptthemen laut MEDLINE: Ferroptosis, Antioxidants, Biological Assay. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Ferroptosis is an iron-dependent form of regulated cell death characterized by the uncontrolled accumulation of lipid peroxides, primarily within phospholipid membranes. This oxidative process, driven by a radical-mediated chain reaction known as autoxidation, plays a central role in numerous pathological conditions including neurodegeneration, ischemia-reperfusion injury, and cancer. Pharmacological inhibition of lipid peroxidation by radical-trapping antioxidants (RTAs) has thus emerged as a promising strategy for therapeutic intervention. However, conventional 'antioxidant assays' such as 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2'-azinobis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) or oxygen radical absorbance capacity (ORAC) are inadequate for assessing reactivity toward lipid peroxyl radicals, limiting their utility in ferroptosis research. To address this gap, the Fluorescence-ENabled Inhibited autoXidation (FENIX) platform was developed as a physiologically relevant, high-throughput assay system for the mechanistic and kinetic characterization of lipid peroxidation inhibitors. FENIX-1 quantifies RTA activity by measuring rate constants for RTA-lipidperoxyl radical reactions initiated by a highly lipid-soluble radical initiator in liposomal systems wherein a fluorescent reporter is co-autoxidized along with the lipids. In FENIX-2 lipid peroxidation is initiated via iron-mediated decomposition of pre-formed phospholipid hydroperoxides, enabling the study of both RTA and non-RTA inhibitors, including iron chelators and peroxidase mimics. Together, these assays are complementary and mechanistically informative platforms for the identification and evaluation of inhibitors of lipid peroxidation and - by extension - ferroptosis. Here, we present a detailed overview and standardized protocols for both FENIX-1 and FENIX-2, with the aim of encouraging their application in lipid peroxidation research, ferroptosis modulation, and redox-targeted drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany.
- Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Canada.
- Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany; Stuttgart Research Center Systems Biology, University of Stuttgart, Stuttgart, Germany. Electronic address: markus.morrison@izi.uni-…
- Stuttgart Research Center Systems Biology, University of Stuttgart, Stuttgart, Germany. Electronic address: dpratt@uottawa.ca.
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Hüther, J. A., Mallais, M., Rehm, M., & Pratt, D. A. (2026). Implementation of the FENIX assay to assess the anti-ferroptotic properties of test compounds. Methods in Cell Biology, 63-83. https://doi.org/10.1016/bs.mcb.2026.01.013
Vancouver
Hüther JA, Mallais M, Rehm M, Pratt DA. Implementation of the FENIX assay to assess the anti-ferroptotic properties of test compounds. Methods in Cell Biology. 2026:63-83. doi:10.1016/bs.mcb.2026.01.013
BibTeX
@article{Hther2026,
author = {Hüther, Juliana A and Mallais, Melodie and Rehm, Markus and Pratt, Derek A},
title = {Implementation of the FENIX assay to assess the anti-ferroptotic properties of test compounds},
journal = {Methods in Cell Biology},
year = {2026},
pages = {63--83},
doi = {10.1016/bs.mcb.2026.01.013}
}
EUVIMED